Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > Rosenberg, tell me...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Mil_Man54on Sep 21, 2021 5:50pm
51 Views
Post# 33896231

RE:RE:RE:RE:Rosenberg, tell me...

RE:RE:RE:RE:Rosenberg, tell me...Somebody call the burn ward.....LOL.......well I guess I've learned my lesson not to mess with Rosenberg......not with comebacks like that.......LOL.....

DavidRosenberg wrote:
Mil_Man54 wrote: LOL.....can Rosenberg be any more clueless.......oh...here's the link....yet he'll copy and paste every word of a PR release multiple times to make sure investors got it.......maybe there's something in those financials that don't look to good......oooohhhh.....scary......LOL....and he should have said as long as they have investor's money.....and having enough to start a clinical trail is a far cry from having enough to finish one.....Rosenberg whould ask AD and the BoD to take a pay cut ...you know to ensure they have enough money......Rosenberg shoudl take one too....

DavidRosenberg wrote:
JAKPUG4LIFE wrote: Why you never talk about financials of the company? All the info is there, just videos and hopes and comparing other companies that are not even on par with fsd




Financial statements can be found here : https://sedar-filings.thecse.com/00000184/2108121548572471.pdf

As long as they have money and wont go bankrupt i dont mind

They have the dough to start clinical trials so that's a plus

 


Sorry that you think im clueless that's unfortunate

I hope one day you can be less clueless than I


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities